Validation results confirm Cellsense EMERIS to be high precision laboratory tool for biodegradation tests

Industrial Lubrication and Tribology

ISSN: 0036-8792

Article publication date: 1 February 2000

Keywords

Citation

(2000), "Validation results confirm Cellsense EMERIS to be high precision laboratory tool for biodegradation tests", Industrial Lubrication and Tribology, Vol. 52 No. 1. https://doi.org/10.1108/ilt.2000.01852aad.008

Publisher

:

Emerald Group Publishing Limited

Copyright © 2000, MCB UP Limited


Validation results confirm Cellsense EMERIS to be high precision laboratory tool for biodegradation tests

Validation results confirm Cellsense EMERIS to be high precision laboratory tool for biodegradation tests

Applications in production of petrochemicals

Keyword: Biodegradibility

A validation process for the Cellsense EMERIS respirometer carried out at AstraZeneca's Brixham Environmental Laboratory, and based on OECD 301F guidelines has demonstrated the system to be a versatile and high precision laboratory tool for the performance of biodegradation tests (see Plate 1).

Biodegradation information is becoming increasingly important to describe the behaviour of both compounds and chemicals in manufacturing processes, including petrochemicals production.

Plate 1Cellsense Limited "The Emeris system"

The Cellsense EMERIS determines changes in the oxygen demand of biological materials, reflecting toxicity or biodegradability. It is a microprocessor-based respirometer that operates 20 individually controlled channels housed in two environmental cabinets. The two cabinets, which can be operated simultaneously from a single control system, feature individual temperature control and house up to ten channels each.

Designed for both short and long term studies, the Cellsense EMERIS is capable of unattended operation for 2,500 hours. Real time data is available on screen throughout, enabling the user to determine whether a test needs to run for the originally specified time, or whether sufficient data have been collected to allow cessation. This particular benefit to industry provides a faster response in the development of new products, with consequences for cost containment.

Copies of the full validation report, together with details of the Cellsense EMERIS system, can be obtained from Cellsense Limited. Tel: 00 44 1223 414344; Fax: 00 44 1223 411300.